Ep. 205 Weight Loss Medications & Impact on OSA with Dr. John Carter and Dr. Michael Weber

Ep. 205 Weight Loss Medications & Impact on O...

Up next

Ep. 258 Understanding Sublingual vs. Subcutaneous Immunotherapy with Dr. Nikhila Schroeder

When allergy meds aren’t enough, how do you choose the form of immunotherapy that will work best for your patient? Board-certified allergist-immunologist Dr. Nikhila Schroeder and host Dr. Basil Kahwash answer that question and more in this episode of the BackTable ENT Podcast. - ...  Show more

Ep. 257 Understanding Eosinophilic Esophagitis: Diagnosis & Treatment Strategies with Dr. John Leung

Think beyond the esophagus. Up to 75% of eosinophilic esophagitis (EoE) patients have ENT-relevant atopic disease that is often best managed with a multidisciplinary approach. Get caught up on best practices in EoE diagnosis and treatment with this episode of the BackTable ENT Po ...  Show more

Recommended Episodes

122 | How to Support Patients on Obesity Medications: A Short Course on Side Effects, Satiety & Supplements
Exam Room Nutrition: Where Busy Clinicians Learn About Nutrition

Join The Obesity Medicine Nutrition Course! Enter code POD15 at checkout for 15% off!

Anti-obesity medications are everywhere—but they also come with new challenges. From rapid weight loss and side effects to TikTok- ...

  Show more

Obesity Rx: How to Use New Medications in Clinic
Medscape InDiscussion: Obesity

Drs Robert Kushner and obesity pharmacotherapy expert Ania Jastreboff discuss how to use the new obesity medications effectively in clinic. Tune in to hear expert recommendations on patient communication, side effects, and more. Relevant disclosures can be found with the episode ...  Show more

The Weight Loss Trends Episode
Beaumont HouseCall Podcast

In this episode, we delve into some of the latest weight loss trends and take a closer look at two drugs specifically, Wegovy and Ozempic. Our guest, Dr. Dana Kerges, a family medicine doctor board certified in obesity medicine, shares valuable insights on the latest weight loss ...  Show more

#320 – AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape
The Peter Attia Drive

View the Show Notes Page for This Episode

<a href= "https://peterattiamd.com/subscribe/?utm_source=podcast-feed ...

  Show more